Logo image of MVBF

MVB FINANCIAL CORP (MVBF) Stock Analyst Ratings

NASDAQ:MVBF - Nasdaq - US5538101024 - Common Stock - Currency: USD

18.5  -0.02 (-0.11%)

After market: 18.5 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to MVBF. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 21.42. This target is 15.78% above the current price.
MVBF was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MVBF.
In the previous month the buy percentage consensus was at a similar level.
MVBF was analyzed by 9 analysts. More opinions would make the average more meaningful.
MVBF Historical Analyst RatingsMVBF Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -75 -68 -61 -54 -47 -40 -33 -26 -19 -12 -5 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 18.5020.2020.4021.4224.15 - 9.19% 10.27% 15.78% 30.54%
MVBF Current Analyst RatingMVBF Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-04-02 Raymond James Maintains Outperform -> Outperform
2025-03-03 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-12-04 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-07-31 JP Morgan Maintains Overweight -> Overweight
2024-05-01 JP Morgan Maintains Overweight -> Overweight
2024-04-04 JP Morgan Maintains Overweight -> Overweight
2024-03-01 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-02-20 JP Morgan Maintains Overweight -> Overweight
2023-07-31 Raymond James Maintains Outperform -> Outperform
2023-05-16 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2023-05-03 Raymond James Maintains Outperform
2023-04-06 Keefe, Bruyette & Woods Maintains Outperform
2023-04-06 Raymond James Maintains Outperform
2023-02-27 JP Morgan Initiate Overweight
2023-02-21 Raymond James Reiterate Outperform
2022-07-07 Raymond James Maintains Strong Buy
2022-05-06 Raymond James Maintains Strong Buy
2021-03-12 Piper Sandler Downgrade Overweight -> Neutral